CERTAIN ISSUES OF PROVIDING MEDICAL CARE TO ELITE AND AMATEUR ATHLETES IN THE LIGHT OF THE ANTI-DOPING PROGRAM
Introduction: In providing medical care to both professional and amateur athletes, sports physicians and primary care physicians must have a certain amount of anti-doping knowledge.
Objective: To analyze the literature sources on the current state of the main existing international anti-doping standards: for sports doctors of national teams and children's sports schools, doctors of sports medicine centers and fitness clubs, as well as general practitioners.
Search strategy: The search and analysis of relevant information: of regulation of anti-doping policy, databases and search engines: Pubmed, Cochrane Library, Scopus, Google Scholar, eLIBRARY, Cyberleninka. The depth of the survey was 20 years.
Results: An analysis of the literature data showed that today the huge variety of existing pharmacological agents in sports needs their systematization, study of the mechanisms of influence and determination of the basic principles of use and is an urgent problem studied at the world level. The results of the analysis also showed the need for further study of sports pharmacology.
Conclusion: Physicians and health professionals play an important role in the athlete’s lives. Knowledge and understanding of the specifics when providing medical care to an athlete is imperative. When prescribing drugs and dietary supplements, it is necessary to be aware of the possible risks of anti-doping rule violations. Before prescribing any medication to an athlete, it is important to check it for prohibited substances in sport.
Kulman S. Nyssanbaeva1, https://orcid.org/0000-0003-1239-8610
Venera A. Abdulla1, https://orcid.org/0000-0002-6133-1298
Мaira K. Bakasheva2, Gulzada Z. Abdushukurova3, https://orcid.org/0000-0002-0398-7678
Raida I. Faizova4, https://orcid.org/0000-0002-7168-6826
Dominic Sagoe5, https://orcid.org/0000-0002-1902-9378
Natalya E. Glushkova6, https://orcid.org/0000-0003-1400-8436
1 Kazakhstan Medical University "Higher School of Public Health", Almaty c., Republic of Kazakhstan;
2 RSE "National Anti-Doping Center" of the Committee for Sports and Physical Culture of the Ministry of Culture and Sports of the Republic of Kazakhstan, Almaty c., Republic of Kazakhstan;
3 International Kazakh-Turkish University named after H.A. Yasaw, Shymkent c., Republic of Kazakhstan.
4 NJSC “Medical university of Semey”, Semey c., Қазақстан Республикасы;
5University of Bergen, Bergen, Norway
6Al-Farabi Kazakh National University, Almaty c., Republic of Kazakhstan.
1. Всемирное антидопинговое агентство Между-народный стандарт по терапевтическому использо-ванию https://rusada.ru/upload/iblock/cbb/Стандарт по ТИ_А5_2020_prev-7.pdf (дата обращения: 05.02.2022).
2. Национальный антидопинговый центр Казахстана - Антидопинговый центр KazNADC. Жарыста адал бол! Играй честно! Play true! [Электронный ресурс]. URL: https://kaznadc.kz/about-us/ (дата обращения: 16.01.2022).
3. О создании республиканского государствен-ного учреждения "Национальный антидопинговый центр «Агентства Республики Казахстан по делам спорта и физической культуры» - ИПС «Әділет» https://adilet.zan.kz/rus/docs/P1200001718 (дата обращения: 16.01.2022).
4. О ратификации Международной конвенции о борьбе с допингом в спорте - ИПС «Әділет». https://adilet.zan.kz/rus/docs/Z090000220 (дата обращения: 16.01.2022).
5. Alaranta A., Alaranta H., Helenius I. Use of prescription drugs in athletes // Sports Medicine. 2008. № 6 (38). C. 449–463.
6. American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction Context // Journal of Clinical Oncology.2009. № 19 (27).С.3235-3258
7. Anderson L.J., Tamayose J.M., Garcia J.M. Use of Growth Hormone, IGF-I, and Insulin for Anabolic Purpose: Pharmacological Basis, Methods of Detection, and Adverse Effects HHS Public Access // Mol Cell Endocrinol. 2018. (464). C. 65–74.
8. Baggish A.L. et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use // Circulation. 2017. № 21 (135). C. 1991–2002.
9. Bahrke M.S., Yesalis C.E., Brower K.J. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents // Child and Adolescent Psychiatric Clinics of North America. 1998. Т.7. №4. C. 821–838.
10. Bailes J., Soloviev M., Donato F. biomolecules Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports 2021.
11. Botrè F., Pavan A. Enhancement Drugs and the Athlete // Physical Medicine and Rehabilitation Clinics of North America. 2009. № 1 (20). C. 133–148.
12. Brennan B.P. et al. Human Growth Hormone Abuse in Male Weightlifters.
13. Brown J.T. Anabolic steroids: What should the emergency physician know? // Emergency Medicine Clinics of North America. 2005. № 3 SPEC. ISS. (23). C. 815–826.
14. Cadwallader A.B. et al. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysisb ph_789 1.16 // British Journal of Pharmacology. 2010. (161). C. 1–16.
15. Davis E. et al.The rush to adrenaline: drugs in sport acting on the b-adrenergic system // British Journal of Pharmacology. 2008. (154). C. 584–597.
16. Eichner E.R. Stimulants in sports // Current Sports Medicine Reports. 2008. № 5 (7). C. 244–245.
17. Elliott S. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport // British Journal of Pharmacology. 2008. (154). C. 529–541.
18. Handelsman D.J. Clinical review: The rationale for banning human chorionic gonadotropin and estrogen blockers in sport // Journal of Clinical Endocrinology and Metabolism. 2006. Т. 91. № 5. C. 1646–1653.
19. Hartgens F., Kuipers H. Effects of Androgenic-Anabolic // Sports Medicine. 2004. November (34). C. 513–554.
20. Heuberger J.A., et al. Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects // Sports Medicine. 2019. (49). C. 525–539.
21. Holt R., Sönksen P. H. Growth hormone, IGF-I and insulin and their abuse in sport // British Journal of Pharmacology. 2008. (154). C. 542–556.
22. Kamalakkannan G. et al. Clenbuterol Increases Lean Muscle Mass but Not Endurance in Patients With Chronic Heart Failure // Journal of Heart and Lung Transplantation. 2008. № 4 (27). C. 457–461.
23. Liu J. Di, Wu Y. Q., Cui Y. Anabolic-androgenic steroids and cardiovascular risk // Chinese Medical Journal. 2019. Т. 132. № 18. C. 2229–2236.
24. Lorente F.O. et al. Cannabis use to enhance sportive and non-sportive performances among French sport students // Addictive Behaviors. 2005. № 7 (30). C. 1382–1391.
25. Marinas M. et al. A nuclear magnetic resonance (1 H and 13 C) and isotope ratio mass spectrometry ( d 13 C , d 2 H and d 18 O ) study of Andalusian olive oils // Rapid Communications in Mass Spectrometry. 2010. (24). C. 1457–1466.
26. Marriot-Lloid P. International Convention against Doping in Sport; 2010. С. 4-6
27. Maughan R.J., Depiesse F., Geyer H. The use of dietary supplements by athletes // Journal of Sports Sciences. 2007. № SUPPL. 1 (25). C. 103–113.
28. Meinhardt U. et al. The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes // Annals of Internal Medicine. 2010. № 152(9). С.568-579.
29. Momaya A., Fawal M., Estes R. Performance-Enhancing Substances in Sports: A Review of the Literature // Sports Medicine. 2015. № 4 (45). C. 517–531.
30. Nordsborg N. et al. Effect of dexamethasone on skeletal muscle Na + ,K + pump subunit specific expression and K + homeostasis during exercise in humans // J Physiol. 2008. (586). C. 1447–1459.
31. Pluim B.M. et al. β2-Agonists and physical performance: A systematic review and meta-analysis of randomized controlled trials // Sports Medicine. 2011. № 1 (41). C. 39–57.
32. Pope H.G. et al. Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement // Endocrine Reviews. 2014. Т. 35. № 3. C. 341–375.
33. Prohibited List Q&A | World Anti-Doping Agency [Электронный ресурс]. URL: https://www.wada-ama.org/en/questions-answers/prohibited-list-qa (дата обращения: 16.01.2022).
34. Riiser A. et al. Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: a systematic review and meta-analysis of randomised controlled trials.
35. Sagoe D. et al. The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis // Annals of Epidemiology. 2014. Т. 24. № 5. C. 383–398.
36. Schobersberger W. et al. Story behind meldonium-from pharmacology to performance enhancement: A narrative review // British Journal of Sports Medicine. 2017. № 1 (51). C. 22–25.
37. Sjöqvist F., Garle M., Rane A. Use of doping agents, particularly anabolic steroids, in sports and society Prevalence of doping in sport and society. 2008.
38. Stone M. R. et al. Exploring the performance reserve: Effect of different magnitudes of power output deception on 4,000 m cycling time-trial performance 2017.
39. Stuart M. et al. Meldonium use by athletes at the Baku 2015 European Games.
40. Who We Are | World Anti-Doping Agency [Электронный ресурс]. URL: https://www.wada-ama.org/en/who-we-are (дата обращения: 16.01.2022).
41. Wolraich M.L. et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. 2019.
42. World Anti-Doping Code | World Anti-Doping Agency. URL: https://www.wada-ama.org/en/resources/the-code/world-anti-doping-code (дата обращения: 16.01.2022).
References: [1-4]
1. Vsemirnoe antidopingovoe agentstvo Mezhdunarodnyi standart po terapevticheskomu ispol'zovaniyu [World Anti-doping Agency International Standard for Therapistic Use Exemptions]. https://rusada.ru/upload/iblock/cbb/Standart po TI_A5_2020_prev-7.pdf (accessed: 05.02.2022)
2. Natsional'nyi antidopingovyi tsentr Kazakhstana — Antidopingovyi tsentr KazNADC | Zharysta ADAL BOL! Igrai chestno! Play true! [RSE "National Anti-Doping Center" of the Committee for Sports and Physical Culture of the Ministry of Culture and Sports of the Republic of Kazakhstan. Play true!]. https://kaznadc.kz/about-us/ (accessed: 16.01.2022).
3. O sozdanii respublikanskogo gosudarstvennogo uchrezhdeniya "Natsional'nyi antidopingovyi tsentr «Agentstva Respubliki Kazakhstan po delam sporta i fizicheskoi kul'tury» - IPS «Әdіlet» [The establishment of the republic state institution "National Anti-Doping Center" of the Agency of the Republic of Kazakhstan for Sports and Physical Culture" - ILS "Adilet]. https://adilet.zan.kz/rus/docs/ (accessed: 16.01.2022).
4. O ratifikatsii Mezhdunarodnoj konvencii o bor'be s dopingom v sporte - IPS «Әdіlet» [On ratification of the International Convention against Doping in Sport-"Adilet" ILS].https://adilet.zan.kz/rus/docs/Z0900 (accessed: 16.01.2022).
Number of Views: 155
Category of articles:
Reviews
Bibliography link
Nyssanbaeva K.S., Abdulla V.A., Bakasheva M.K., Abdushukurova Gulzada Z., Faizova R.I., Dominik S., Glushkova N. Certain issues of providing medical care to elite and amateur athletes in the light of the anti-doping program // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 2, pp. 112-122. doi 10.34689/SH.2022.24.2.014Related publications:
INTERRELATION OF INTRAABDOMINAL HYPERTENSION AND MARKERS OF GASTROINTESTINAL TRACT INJURY IN PATIENTS WITH MULTIORGAN DYSFUNCTION
DRUG-INDUCED LIVER INJURY AND GENDER DIFFERENCES
QUALITY OF LIFE IN PRIMARY BILIARY CHOLANGITIS AND ITS ASSESSMENT
DIAGNOSTIC AND THERAPEUTIC LAPAROSCOPY FOR ABDOMINAL INJURIES. REVIEW
METHODS FOR SCHOOL-AGE CHILDREN NUTRITIONAL STATUS ASSESSMENT: FOCUS ON ANTHROPOMETRIC PARAMETERS. A REVIEW.